Brokers’ take: RHB raises Raffles Medical’s target price to S$1.35 on Singapore’s reopening plans

RHB stated in a research note on Thursday that RAFFLES Medical’s near-term earnings will likely benefit from loosening restrictions and efforts to reopen Singapore’s borders./nRead More